CASTRICONI, ROBERTA
 Distribuzione geografica
Continente #
EU - Europa 8.592
AS - Asia 392
SA - Sud America 52
NA - Nord America 39
AF - Africa 12
Totale 9.087
Nazione #
IT - Italia 8.584
SG - Singapore 173
CN - Cina 105
VN - Vietnam 91
BR - Brasile 33
US - Stati Uniti d'America 27
AR - Argentina 10
MX - Messico 10
HK - Hong Kong 8
ID - Indonesia 6
EC - Ecuador 4
BD - Bangladesh 3
AO - Angola 2
CA - Canada 2
CL - Cile 2
GB - Regno Unito 2
MA - Marocco 2
OM - Oman 2
PT - Portogallo 2
AT - Austria 1
BF - Burkina Faso 1
CO - Colombia 1
DE - Germania 1
DJ - Gibuti 1
DZ - Algeria 1
EG - Egitto 1
IE - Irlanda 1
IN - India 1
JO - Giordania 1
MU - Mauritius 1
PH - Filippine 1
PY - Paraguay 1
RU - Federazione Russa 1
SN - Senegal 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 9.087
Città #
Genova 5.089
Genoa 2.153
Rapallo 666
Vado Ligure 640
Singapore 53
Beijing 36
Ho Chi Minh City 31
Bordighera 24
Hanoi 18
Ashburn 15
Hong Kong 8
Tianjin 7
Mexico City 6
Da Nang 5
Milan 5
Biên Hòa 4
Jakarta 4
Thái Nguyên 4
Haiphong 3
Hải Dương 3
Ninh Bình 3
Bra 2
Buenos Aires 2
Cao Lanh 2
Luanda 2
New York 2
Phủ Lý 2
Portico di Caserta 2
Quảng Ngãi 2
Rabat 2
Seeb 2
São Paulo 2
Acaraú 1
Alcanena 1
Amman 1
Anápolis 1
Atlanta 1
Avaré 1
Avellaneda 1
Baie-D'Urfé 1
Barquisimeto 1
Barra Bonita 1
Barra Mansa 1
Belém 1
Benito Juarez 1
Boa Vista 1
Bogotá 1
Boituva 1
Bologna 1
Brasília 1
Bình Dương 1
Cachoeiras de Macacu 1
Cairo 1
Castanhal 1
Chascomús 1
Chicago 1
Chordeleg 1
Clorinda 1
Copiapó 1
Cuenca 1
Curitiba 1
Dakar 1
Dallas 1
Del Viso 1
Denver 1
Dhaka 1
Dublin 1
Duque de Caxias 1
Estación Colina 1
Esteio 1
Farroupilha 1
Finale Ligure 1
Foz do Iguaçu 1
Grand Rapids 1
Guayaquil 1
Hưng Yên 1
Itapevi 1
Johannesburg 1
Joinville 1
José Bonifácio 1
Lages 1
Lajeado 1
Lisbon 1
Madurai 1
Magé 1
Makhachkala 1
Manchester 1
Mar del Plata 1
Mercês 1
Miguel Hidalgo 1
Montes Claros 1
Nova Lima 1
Nuremberg 1
Ouagadougou 1
Phú Thọ 1
Port Louis 1
Prudentópolis 1
Puebla City 1
Ribeirão das Neves 1
Rio de Janeiro 1
Totale 8.867
Nome #
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 219
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 214
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches. 199
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 199
Both CD133(+) and CD133(-) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity 195
Main NK cell receptors and their ligands: regulation by microRNAs 193
Function and specificity of human natural killer cell receptors. 170
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 169
Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells 168
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells 167
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. 166
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. 163
Identification of NKp80, a novel triggering molecule expressed by human NK cells. 159
Human NK cells and NK receptors 155
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 154
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors 153
CIS is a negative regulator of IL-15-mediated signals in NK cells 150
Cellular ligands for activating NK receptors 147
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 146
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. 146
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 145
Natural killer lymphocytes: "null cells" no more. 142
Cell-laden hydrogel as a clinical-relevant 3D model for analyzing neuroblastoma growth, immunophenotype, and susceptibility to therapies 141
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction 137
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 137
Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. 137
Expression of the DNAM-1 ligands Nectin-2 (CD112) and poliovirus receptor (CD155) on dendritic cells: relevance for natural killer/dendritic cells interaction 137
Pathogen-induced private conversations between natural killer and dendritic cells 135
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells. 134
Imatinib and nilotinib off-target effects on human NK cells, monocytes, and M2 macrophages 134
TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells. 133
Overview of the Soluble and Membrane-bound Tumor Factors Limiting NKmediated Immune Surveillance 132
Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1 132
The leukocyte Ig-like receptor (LIR)-1 for the Cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1+ NK cell clones 130
Cytokine-induced expression of killer inhibitory receptors in human T lymphocytes 130
Neuroblastoma-derived transforming growth factor (TGF) β1 modulates the chemokine receptor repertoire of human resting Natural Killer Cells. 129
Neuroblastoma-Derived TGF-beta1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells. 128
Immunotherapy in the Treatment of Human Solid Tumors: Basic and Translational Aspects 128
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin 126
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 124
TGF-beta1 downregulates the expression of CX3CR1 by inducing miR-27a-5p in primary human NK cells 121
New perspectives in glioma immunotherapy. 119
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency 118
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences on the NK-mediated killing of dendritic cells 117
The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition 115
Shaping of adaptive immunity by innate interactions 114
Neuroblastoma Cells Modulate Chemokine Receptor Repertoire of Resting NK Cells 114
NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. 113
Identification of 4Ig-B7-H3 as a novel neuroblastoma-associated molecule that exerts a protective role from natural killer cell-mediated lysis 113
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule 113
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma 110
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes (LDGL) 109
Identification of a novel neuroblastoma-associated molecule that protects from NK-mediated lysis 108
Therapeutic and diagnostic methods and compositions targeting 4IG-B7-H3 and its counterpart NK cell receptor 106
Natural Killer cells recognize and kill human glioblastoma cells with stem cell-like properties 101
Su.64. Natural Killer Cell-mediated Recognition of Human Brain Tumors 100
A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model 99
The SIICA School of Immunology 2017: a gathering for NGS (next generation scientists) 96
Elementi di istologia e cenni di embriologia 96
Selective cross-talk among natural cytotoxicity receptors in human natural killers cells 95
Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies 93
ISTOLOGIA di Monesi 7 87
TGFβ1 inhibits the surface expression of the NKp30 and NKG2D triggering NK receptors: consequences for the NK-mediated killing of dendritic cells 85
B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma 81
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine /chemokine secretion in CD56(bright) and CD56(dim) NK cells 69
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants 69
Surface NK receptors and their ligands on tumors cells 67
Inhibitory axes impacting on the activity and fate of Innate Lymphoid Cells 66
Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants 66
NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms 63
High-dimensional single-cell analysis of human natural killer cell heterogeneity 54
Editorial: Recent 3D Tumor Models for Testing Immune-Mediated Therapies 49
Monocyte and Macrophage in Neuroblastoma: Blocking Their Pro-Tumoral Functions and Strengthening Their Crosstalk with Natural Killer Cells 44
miR-24-3p down-regulates the expression of the apoptotic factors FasL and BIM in human natural killer cells 43
Editorial: TGF-β as a Key Regulator of NK and ILCs Development and Functions 39
Natural killer cells and engagers: Powerful weapons against cancer 21
Membrane IL-18 identifies a human macrophage subset with distinct proteomic and functional traits 17
Exosomes and immune modulation: implications for neuroblastoma immunotherapy 8
Immunomodulatory Mechanisms Impacting the Activity and Fate of Natural Killer Cells in Cancer 4
Totale 9.305
Categoria #
all - tutte 30.338
article - articoli 28.939
book - libri 604
conference - conferenze 320
curatela - curatele 0
other - altro 0
patent - brevetti 259
selected - selezionate 0
volume - volumi 216
Totale 60.676


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021348 0 0 0 0 0 84 15 49 44 76 29 51
2021/2022852 34 79 66 113 14 53 43 201 38 70 39 102
2022/2023820 81 72 11 85 126 144 3 60 147 6 69 16
2023/2024489 22 69 15 78 29 52 27 38 33 23 43 60
2024/20251.506 25 103 84 91 211 147 176 232 41 67 147 182
2025/20261.202 290 69 170 210 399 64 0 0 0 0 0 0
Totale 9.305